Zhang Zichen, Ren Wenbo, Wang Yifei, Zhai Taiyu, Huang Jing
Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China.
College of Medical Technology, Beihua University, Jilin, China.
Ann Med. 2025 Dec;57(1):2560605. doi: 10.1080/07853890.2025.2560605. Epub 2025 Sep 16.
Circulating microbial DNA (cmDNA) is a significant biomarker involved in normal physiology, immunity, disease diagnosis, and pathogenesis. Its origin in peripheral blood has sparked extensive discussions and generated numerous hypotheses.
This review explores four potential sources of cmDNA in the blood and analyzes research limitations and future prospects.
Four potential sources are collated and analyzed: exogenous microbes or DNA entering the peripheral blood after barrier damage; residual pathogen DNA remaining after infectious diseases; microbial translocation from sites such as the oral and intestinal mucosa into the bloodstream; and the extracellular vesicle delivery system, where microorganisms release vesicles to transfer DNA.
The potential sources of cmDNA in the blood are not mutually exclusive and may be multifaceted, depending on an individual's health condition, sampling time, and contamination control. In-depth study of these sources will open new avenues for early disease detection, precise diagnosis, and prognosis assessment, and encourage further exploration in this promising field.
循环微生物DNA(cmDNA)是参与正常生理、免疫、疾病诊断和发病机制的重要生物标志物。其在外周血中的起源引发了广泛讨论并产生了众多假说。
本综述探讨血液中cmDNA的四种潜在来源,并分析研究局限性和未来前景。
整理并分析了四种潜在来源:屏障受损后进入外周血的外源微生物或DNA;传染病后残留的病原体DNA;微生物从口腔和肠道黏膜等部位转移到血液中;以及细胞外囊泡递送系统,即微生物释放囊泡来转移DNA。
血液中cmDNA的潜在来源并非相互排斥,可能是多方面的,这取决于个体的健康状况、采样时间和污染控制。对这些来源的深入研究将为疾病的早期检测、精准诊断和预后评估开辟新途径,并鼓励在这一充满前景的领域进行进一步探索。